FeaturesSignalPricingFounders
Log inGet started free
SO

SR One

Corporate VCActive

SR One is the corporate venture capital arm of GlaxoSmithKline.

Cambridge, United StatesFounded 2019srone.com/
144
Investments
41
Exits
$719M
AUM
28.5%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for SR One.

Get started free

Investment Thesis & Strategy

SR One invests in various stages of fintech, healthcare, and venture capital companies, leveraging its parent company's expertise in the healthcare sector.

Investment Activity

Deals per year over the last 7 years

2
2014
2
2015
0
2016
2
2017
2
2018
3
2019
1
2020

Portfolio Companies

Selected investments from their portfolio of 144 companies

P
Palleon Pharmaceuticals
Biotech · Series A, 2020
Active
C
Cellarity
Biotech · Series A, 2019
Active
T
Tessera Therapeutics
Biotech · Series A, 2019
Active
X
Xilio Therapeutics
Biotech · Series A, 2019
Active
C
Cerevel Therapeutics
Biotech · Series A, 2018
Active
V
Vaxcyte
Biotech · Series A, 2018
Active
A
Alector
Biotech · Series A, 2017
Active
O
Obsidian Therapeutics
Biotech · Series A, 2017
Active
C
Compass Therapeutics
Biotech · Series A, 2015
Active
R
Revolution Medicines
Biotech · Series A, 2015
Active
K
Kura Oncology
Biotech · Series A, 2014
Active
A
Autolus Therapeutics
Biotech · Series A, 2014
Active

Frequently Asked Questions

SR One focuses on Series A, Series B stage investments.

Related Investors

Sanofi Ventures

Cambridge, United States · 37 deals

Johnson & Johnson Innovation – JJDC

Cambridge, United States · 34 deals

Johnson & Johnson Innovation вАУ JJDC

Cambridge, United States · 34 deals

Baxalta Ventures

Cambridge, United States · 6 deals

Partners HealthCare Innovation

Cambridge, United States · 1 deals

Brand Capital

Mumbai, India · 570 deals